Koers Critical Outcome Technologies Inc. Other OTC
Aandelen
CA22675B1031
Biotechnologie & Medisch Onderzoek
Omzet 2018 | - | Omzet 2019 | - | Marktkapitalisatie | 1,61 mln. 1,49 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2018 | -4 mln. -3,69 mln. | Nettowinst (verlies) 2019 | -2 mln. -1,85 mln. | EV/omzet 2018 | - |
Nettoliquiditeiten 2018 | 40,73K 37,61K | Nettoliquiditeiten 2019 | 24,64K 22,75K | EV/omzet 2019 | - |
K/w-verhouding 2018 |
-1,11
x | K/w-verhouding 2019 |
-0,6
x | Werknemers | - |
Dividendrendement 2018 * |
-
| Dividendrendement 2019 |
-
| Vrij verhandelbaar | 69,18% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Alison D. Silva
PSD | President | 46 | 01-01-15 |
Debi Sanderson
COO | Chief Operating Officer | - | - |
Chief Tech/Sci/R&D Officer | 61 | 12-06-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 63 | 01-07-18 | |
John C. Drake
CHM | Chairman | - | 20-02-07 |
Alison D. Silva
PSD | President | 46 | 01-01-15 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+9,99% | 114 mld. | |
+12,01% | 107 mld. | |
-3,07% | 22,22 mld. | |
-0,67% | 21,28 mld. | |
-4,64% | 18,8 mld. | |
-6,90% | 17,51 mld. | |
-39,36% | 17,17 mld. | |
+5,82% | 14,14 mld. | |
+33,05% | 12,2 mld. |